Filtered news list testing
List of Reports
.pdf
03/20/2024 - 2023 Full-year results
.pdf
08/02/2024 - 2023 Revenue
.pdf
10/19/2023 - Revenue at 30 September 2023
.pdf
09/27/2023 - Half-year financial report 2023
.pdf
09/21/2023 - 2023 Half-year results (Presentation)
.pdf
09/20/2023 - 2023 Half Year Results
.pdf
07/20/2023 - First Half 2023 Revenue
.pdf
05/26/2023 - Changes In Guerbet's Board Of Directors
Single report testing
.pdf
test report fabien V 09-07
Separator
Filtered images
Discover the latest news of Guerbet
Latest news
U.S. Food and Drug Administration (FDA) grants Breakthrough Device status to the Guerbet innovation: LIPIOJOINT
U.S. Food and Drug Administration (FDA) grants Breakthrough Device status to the Guerbet innovation: LIPIOJOINT
2024 revenue
2024 revenue
Guerbet, Intrasense, Gustave Roussy and the University Hospital of Angers receive a €5.9M financing from Bpifrance for Liflow®, innovative solution dedicated to oncology imaging
Guerbet, Intrasense, Gustave Roussy and the University Hospital of Angers receive a €5.9M financing from Bpifrance for Liflow®, innovative solution dedicated to oncology imaging